Head of Biogen PO&T Apellis Unit Supply Chain
Apellis Pharmaceuticals
This listing was originally posted on Apellis Pharmaceuticals's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moOpportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases.
Summary:
The Head of Apellis Supply Chain unit is responsible for the end-to-end supply chain management for all of Biogen’s Apellis clinical and commercial products. The position reports directly to the Head of Apellis Technical Operations at Biogen and is an integral part of the Tech Ops Leadership team. This position is located in either Cambridge MA, or Research Triangle Park, NC.Roles and Responsibilities:
Create the vision for Supply Chain organizational success; define direction, strategies and plans for implementation; communicate vision and plans with all stakeholders across the organization.
Ensure business goals and objectives are achieved. Effectively direct the organization and work with colleagues, and teams within Apellis and Biogen, Commercial and R&D to achieve goals and plans. Accountable for fiscal budget management.
Accountable to effectively oversee the end-to-end flow of materials, information, and products to ensure efficiency, cost reduction, and timely delivery. This includes but is not limited to the accountability for negotiation of contracts and strong relationship management with suppliers, distributors, and 3rd party logistics (3PL) providers; effective management of inventory levels, demand planning, production scheduling, and transportation to ensure efficient distribution; proactive identification of potential issues and bottlenecks, as well as the contingency plans for potential supply disruptions to maintain business continuity.
Evaluate opportunities to move the organization forward, bringing innovative ideas and approaches to the work. Actively champions and holds the organization accountable to uncover customer and market needs to drive continuous improvement.
Develop and maintain a highly capable team of professionals. Ensure continuity of key leadership positions through the development of talent. Anticipate talent needs, build capability where expertise is needed.
C. Minimum Education and Experience Requirements
(inclusive of minimum educational level necessary to perform the job (High School diploma, Associate’s Degree, Bachelor’s Degree, Masters, PhD, etc.), certifications and minimum experience requirements
D. Knowledge & Skills
Travel Requirements:
10% travelEducation:
Pay Information:
Base salary for this role will consider multiple factors, including but not limited to, candidate qualifications, relevant expertise, specialized skills, and industry experience in complement-targeted therapies. The targeted base salary range for this position is $264,000-$373,000. This range represents the base salary only and reflects Apellis' commitment to competitive compensation within the biopharmaceutical industry. The final salary offered may vary based on individual qualifications, business needs, and current market conditions.Work Arrangement:
Benefits and Perks:
Apellis offers a comprehensive benefits package, including a 401(k) plan with company match, inclusive family building benefits, flexible time off, summer and winter shutdowns, paid family leave, disability and life insurance, and more! Visit https://apellis.com/careers/benefits/ to learn more.
SPECIAL NOTE ON BIOGEN ACQUISITION
Please note that as of May 14th, Biogen Inc. has acquired Apellis Pharmaceuticals. Click here to learn more about Benefits & Perks of working at Biogen: Benefits | Biogen
Company Background:
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases.
For more information, please visit http://apellis.com or follow us on LinkedIn and X.
EEO Statement:
Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumoconiosis or any other characteristic protected under applicable federal, state or local law.
For San Francisco postings: Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records.
Other Duties:
Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Apellis Pharmaceuticals?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Cyclic peptide analog
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo